Beef in an Optimal Lean Diet study: effects on lipids, lipoproteins, and apolipoproteins

Michael A Roussell, Alison M Hill, Trent L Gaugler, Sheila G West, John P Vanden Heuvel, Petar Alaupovic, Peter J Gillies, Penny M Kris-Etherton, Michael A Roussell, Alison M Hill, Trent L Gaugler, Sheila G West, John P Vanden Heuvel, Petar Alaupovic, Peter J Gillies, Penny M Kris-Etherton

Abstract

Background: A Step I diet with lean beef compared with lean white meat both decrease LDL cholesterol. To our knowledge, no studies have evaluated a low-saturated fatty acid (SFA) (<7% calories) diet that contains lean beef.

Objective: We studied the effect on LDL cholesterol of cholesterol-lowering diets with varying amounts of lean beef [ie, Dietary Approaches to Stop Hypertension (DASH): 28 g beef/d; Beef in an Optimal Lean Diet (BOLD): 113 g beef/d; and Beef in an Optimal Lean Diet plus additional protein (BOLD+): 153 g beef/d] compared with that of a healthy American diet (HAD).

Design: Thirty-six hypercholesterolemic participants (with LDL-cholesterol concentrations >2.8 mmol/L) were randomly assigned to consume each of the 4 diets (HAD: 33% total fat, 12% SFA, 17% protein, and 20 g beef/d), DASH (27% total fat, 6% SFA, 18% protein, and 28 g beef/d), BOLD (28% total fat, 6% SFA, 19% protein, and 113 g beef/d), and BOLD+ (28% total fat, 6% SFA, 27% protein, and 153 g beef/d) for 5 wk.

Results: There was a decrease in total cholesterol (TC) and LDL-cholesterol concentrations (P < 0.05) after consumption of the DASH (-0.49 ± 0.11 and -0.37 ± 0.09 mmol/L, respectively), BOLD (-0.48 ± 0.10 and -0.35 ± 0.9 mmol/L, respectively), and BOLD+ (-0.50 ± 0.10 and -0.345 ± 0.09 mmol/L, respectively) diets compared with after consumption of the HAD (-0.22 ± 0.10 and -0.14 ± 0.10 mmol/L, respectively). Apolipoprotein A-I, C-III, and C-III bound to apolipoprotein A1 particles decreased after BOLD and BOLD+ diets compared with after the HAD, and there was a greater decrease in apolipoprotein B after consumption of the BOLD+ diet than after consumption of the HAD (P < 0.05 for both). LDL cholesterol and TC decreased after consumption of the DASH, BOLD, and BOLD+ diets when the baseline C-reactive protein (CRP) concentration was <1 mg/L; LDL cholesterol and TC decreased when baseline CRP concentration was >1 mg/L with the BOLD and BOLD+ diets.

Conclusions: Low-SFA, heart-healthy dietary patterns that contain lean beef elicit favorable effects on cardiovascular disease (CVD) lipid and lipoprotein risk factors that are comparable to those elicited by a DASH dietary pattern. These results, in conjunction with the beneficial effects on apolipoprotein CVD risk factors after consumption of the BOLD and BOLD+ diets, which were greater with the BOLD+ diet, provide support for including lean beef in a heart-healthy dietary pattern. This trial was registered at clinicaltrials.gov as NCT00937898.

Figures

FIGURE 1.
FIGURE 1.
Recruitment flow diagram.
FIGURE 2.
FIGURE 2.
Change in lipids and lipoproteins. Mean percentage change (±SEM) from the HAD (HAD: n = 33; DASH: n = 35; BOLD: n = 34; and BOLD+: n = 34). The MIXED procedure in SAS software (version 9.2; SAS Institute Inc) was used to test the effects of diet. *Significantly different from the HAD, P < 0.05. BOLD, Beef in an Optimal Lean Diet; BOLD+, Beef in an Optimal Lean Diet plus additional protein; DASH, Dietary Approaches to Stop Hypertension; HAD, healthy American diet; TC, total cholesterol; TG, triglycerides.

References

    1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–421
    1. 2010 Dietary Guidelines Advisory Committee Report of the Dietary Guidelines Advisory Committee on the dietary guidelines for Americans. : United States Department of Agriculture, ed Washington, DC: US Government Printing Office, 2010
    1. Sinha R, Cross AJ, Graubard BI, Leitzmann MF, Schatzkin A. Meat intake and mortality: a prospective study of over half a million people. Arch Intern Med 2009;169:562–71
    1. Azadbakht L, Esmaillzadeh A. Red meat intake is associated with metabolic syndrome and the plasma C-reactive protein concentration in women. J Nutr 2009;139:335–9
    1. Bernstein AM, Sun Q, Hu FB, Stampfer MJ, Manson JE, Willett WC. Major dietary protein sources and risk of coronary heart disease in women. Circulation 2010;122:876–83
    1. Tasevska N, Sinha R, Kipnis V, Subar AF, Leitzmann MF, Hollenbeck AR, Caporaso NE, Schatzkin A, Cross AJ. A prospective study of meat, cooking methods, meat mutagens, heme iron, and lung cancer risks. Am J Clin Nutr 2009;89:1884–94
    1. Micha R, Wallace SK, Mozaffarian D. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation 2010;121:2271–83
    1. Damião R, Castro TG, Cardoso MA, Gimeno SGA, Ferreira SRG. Dietary intakes associated with metabolic syndrome in a cohort of Japanese ancestry. Br J Nutr 2006;96:532–8
    1. National Cholesterol Education Program Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults ((Adult Treatment Panel II). Circulation 1994;89:1333–445
    1. Hunninghake DB, Maki KC, Kwiterovich PO, Jr, Davidson MH, Dicklin MR, Kafonek SD. Incorporation of lean red meat into a national cholesterol education program Step I diet: a long-term, randomized clinical trial in free-living persons with hypercholesterolemia. J Am Coll Nutr 2000;19:351–60
    1. Davidson MH, Hunninghake D, Maki KC, Kwiterovich PO, Jr, Kafonek S. Comparison of the effects of lean red meat vs lean white meat on serum lipid levels among free-living persons with hypercholesterolemia: a long-term, randomized clinical trial. Arch Intern Med 1999;159:1331–8
    1. Beauchesne-Rondeau E, Gascon A, Bergeron J, Jacques H. Plasma lipids and lipoproteins in hypercholesterolemic men fed a lipid-lowering diet containing lean beef, lean fish, or poultry. Am J Clin Nutr 2003;77:587–93
    1. Vogt TM, Appel LJ, Obarzanek EVA, Moore TJ, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Cutler JA, Windhauser MM, et al. Dietary approaches to stop hypertension: rationale, design, and methods. J Am Diet Assoc 1999;99:S12–8
    1. Erlinger TP, Miller ER, III, Charleston J, Appel LJ. Inflammation modifies the effects of a reduced-fat low-cholesterol diet on lipids: results from the DASH-sodium trial. Circulation 2003;108:150–4
    1. Warnick GR, Albers JJ. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 1978;19:65–76
    1. Riepponen P, Marniemi J, Rautaoja T. Immunoturbidimetric determination of apolipoproteins A-1 and B in serum. Scand J Clin Lab Invest 1987;47:739–44
    1. Morgan C, Lazarow A. Immunoassay of insulin using a two-antibody system. Proc Soc Exp Biol Med 1962;110:29–32
    1. Kraus RM, Stallings H, Yeager R, Gavin T. Circulating plasma VEGF response to exercise in sedentary and endurance-trained men. J Appl Physiol 2004;96:1445–50
    1. Obarzanek E, Sacks FM, Vollmer WM, Bray GA, Miller ER 3rd, Lin PH, Karanja NM, Most-Windhauser MM, Moore TJ, Swain JF, et al. Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr 2001;74:80–9
    1. Appel LJ, Sacks FM, Carey VJ, Obarzanek E, Swain JF, Miller ER 3rd, Conlin PR, Erlinger TP, Rosner BA, Laranjo NM, et al. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 2005;294:2455–64
    1. Taku K, Umegaki K, Sato Y, Taki Y, Endoh K, Watanabe S. Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr 2007;85:1148–56
    1. Smit E, Nieto FJ, Crespo CJ. Blood cholesterol and apolipoprotein B levels in relation to intakes of animal and plant proteins in US adults. Br J Nutr 1999;82:193–201
    1. Mensink RP, Zock PL, Kester ADM, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003;77:1146–55
    1. Kawakami A, Yoshida M. Apolipoprotein C-III links dyslipidemia with atherosclerosis. J Atheroscler Thromb 2009;16:6–11
    1. Cabana VG, Siegel J, Sabesin S. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J Lipid Res 1989;30:39–49
    1. Khovidhunkit W, Memon RA, Feingold KR, Grunfeld C. Infection and Inflammation-induced proatherogenic changes of lipoproteins. J Infect Dis 2000;181:S462–72
    1. Hilpert KF, Kris-Etherton PM, West SG. Lipid response to a low-fat diet with or without soy is modified by C-reactive protein status in moderately hypercholesterolemic adults. J Nutr 2005;135:1075–9
    1. St-Onge M-P, Zhang S, Darnell B, Allison DB. Baseline serum C-reactive protein is associated with lipid responses to low-fat and high-polyunsaturated fat diets. J Nutr 2009;139:680–3
    1. Pearson TA, Mensah G, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499–511

Source: PubMed

3
Abonnere